Literature DB >> 15893696

Increased expression of soluble decoy receptor 3 in acutely inflamed intestinal epithelia.

Sunghee Kim1, Anastasia Fotiadu, Vassiliki Kotoula.   

Abstract

Decoy receptor 3 (DcR3), a soluble receptor in the tumor necrosis factor (TNF) receptor family, is known to inhibit apoptosis mediated by pro-apoptotic TNF family cytokines such as Fas ligand (FasL), TL1A, and LIGHT. Therefore, the regulation of DcR3 expression under certain pathophysiological conditions is of interest since the level of soluble DcR3 would most likely affect the homeostasis of cells and tissues. We found that human intestinal epithelial cell (IEC) lines (SW480, SW620, and HT29) could selectively increase DcR3 release in response to lipopolysaccharide (LPS) and that all the cells preferentially expressed Toll-like receptor 4 (TLR-4). LPS-induced DcR3 releases in IECs appeared to be via the activation of mitogen-activated protein kinases (MAPK) such as extracellular signal-regulated kinase 1 and 2 (ERK1/2) and c-Jun NH2-terminal protein kinase (JNK), and the transcription factor NF-kappaB. Moreover, the increased expression of DcR3 in appendix epithelia from patients with acute appendicitis was demonstrated. Taken together, the results indicated that DcR3 might play an important role in the human intestinal epithelium during acute inflammatory processes caused by endotoxin challenge.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15893696     DOI: 10.1016/j.clim.2005.02.014

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  19 in total

1.  TL1A: a mediator of gut inflammation.

Authors:  Howard A Young; Michael G Tovey
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-22       Impact factor: 11.205

2.  Realigning the LIGHT signaling network to control dysregulated inflammation.

Authors:  Carl F Ware; Michael Croft; Garry A Neil
Journal:  J Exp Med       Date:  2022-05-23       Impact factor: 17.579

3.  DcR3 and survivin are highly expressed in colorectal carcinoma and closely correlated to its clinicopathologic parameters.

Authors:  Qi-lian Liang; Bi-rong Wang; Guo-hong Li
Journal:  J Zhejiang Univ Sci B       Date:  2009-09       Impact factor: 3.066

4.  Elevated serum decoy receptor 3 with enhanced T cell activation in systemic lupus erythematosus.

Authors:  C-S Lee; C-Y Hu; H-F Tsai; C-S Wu; S-L Hsieh; L-C Liu; P-N Hsu
Journal:  Clin Exp Immunol       Date:  2008-01-08       Impact factor: 4.330

5.  Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease.

Authors:  Subra Kugathasan; Robert N Baldassano; Jonathan P Bradfield; Patrick M A Sleiman; Marcin Imielinski; Stephen L Guthery; Salvatore Cucchiara; Cecilia E Kim; Edward C Frackelton; Kiran Annaiah; Joseph T Glessner; Erin Santa; Tara Willson; Andrew W Eckert; Erin Bonkowski; Julie L Shaner; Ryan M Smith; F George Otieno; Nicholas Peterson; Debra J Abrams; Rosetta M Chiavacci; Robert Grundmeier; Petar Mamula; Gitit Tomer; David A Piccoli; Dimitri S Monos; Vito Annese; Lee A Denson; Struan F A Grant; Hakon Hakonarson
Journal:  Nat Genet       Date:  2008-08-31       Impact factor: 38.330

6.  Expression of decoy receptor 3 in diffuse sclerosing variant of papillary thyroid carcinoma: correlation with M2 macrophage differentiation and lymphatic invasion.

Authors:  Wei-Chin Chang; Jui-Yu Chen; Chen-Hsen Lee; An-Hang Yang
Journal:  Thyroid       Date:  2013-05-28       Impact factor: 6.568

7.  Significance of increased expression of decoy receptor 3 in chronic liver disease.

Authors:  S Kim; V Kotoula; P Hytiroglou; D Zardavas; L Zhang
Journal:  Dig Liver Dis       Date:  2009-02-04       Impact factor: 4.088

8.  Significance of decoy receptor 3 (Dcr3) and external-signal regulated kinase 1/2 (Erk1/2) in gastric cancer.

Authors:  Donghai Yang; Xin Fan; Ping Yin; Qiang Wen; Feng Yan; Sibo Yuan; Bin Liu; Guohong Zhuang; Zhongchen Liu
Journal:  BMC Immunol       Date:  2012-06-06       Impact factor: 3.615

9.  Specific elevation of DcR3 in sera of sepsis patients and its potential role as a clinically important biomarker of sepsis.

Authors:  Sunghee Kim; Lijun Mi; Lurong Zhang
Journal:  Diagn Microbiol Infect Dis       Date:  2012-05-29       Impact factor: 2.803

10.  Kruppel-like factor 5 is an important mediator for lipopolysaccharide-induced proinflammatory response in intestinal epithelial cells.

Authors:  Sengthong Chanchevalap; Mandayam O Nandan; Beth B McConnell; Laetitia Charrier; Didier Merlin; Jonathan P Katz; Vincent W Yang
Journal:  Nucleic Acids Res       Date:  2006-02-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.